BSGM Stock, BioSig Technologies Inc. Information

BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the . billion electrophysiology EP marketplace www.biosigtech.com . Led by a proven management team and a veteran, independent Board of Directors, Minneapolis based BioSig Technologies is preparing to commercialize its PURE EP TM System. The technology has been developed to address an unmet need in a large and growing market. The PURE EP System is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and is working toward FDA k clearance for the PURE EP System.